Shorter product development cycles and intense competition are constant threats to new pharmaceutical products or medical devices that often struggle to achieve their profit and volume objectives. Comprehensive understanding of market and patient needs, pricing options and therapeutic benefits, and in particular approval and payment options are critical to overcome these barriers. With extensive experience in the pharmaceutical industry, we work with companies to ensure that their products are optimally priced for rapid market uptake and are tightly aligned with patient, provider and payer needs. To help companies move from developing products to improving patient outcomes, and realizing the benefit of this transition, Syreon Research Institute offers:
- Strategic consultancy
- Product positioning
- Strategic pricing
- Market and patient access strategy
- Development of value framework
- Global value dossier
- Pricing and market access workshop